Cognex Corp (CGNX) Tops Q4 EPS by 8c, Offers Q1 Sales Guidance
Tweet
Share
E-mailGet Alerts CGNX Hot Sheet
Price: $62.25 +2.40%
EPS Growth %: +57.6%
Financial Fact:
Other expense: 374K
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +57.6%
Financial Fact:
Other expense: 374K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cognex Corp (NASDAQ: CGNX) reported Q4 adjusted EPS of $0.48, $0.08 better than the analyst estimate of $0.40. Revenue for the quarter came in at $84 million versus the consensus estimate of $81.49 million.
Cognex Corp sees Q1 2012 revenue of $74-$77 million, versus the consensus of $78.5 million.
For earnings history and earnings-related data on Cognex Corp (CGNX) click here.
Cognex Corp sees Q1 2012 revenue of $74-$77 million, versus the consensus of $78.5 million.
For earnings history and earnings-related data on Cognex Corp (CGNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- JPMorgan Downgrades Woolworths Holdings Ltd (WHL:SJ) to Underweight
- ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
